The MIXiii-Biomed Israel 2018 Conference
We are honored to invite you to participate in MIXiii-Biomed 2018 to be held at the David InterContinental Hotel, Tel Aviv, Israel, May 15-17, 2018. This premiere event is taking place for the 17th consecutive year.
Mixiii-Biomed Israel 2018 follows the success of previous annual conferences: last year’s event drew 6,000 industry players, engineers and scientists, with 1,000 conference participants from 42 countries and in excess of 4,500 one-on-one meetings. We will continue our tradition of keynote speeches and plenary sessions given by industry leaders and prominent academics worldwide. In attendance will be Israel’s most innovative medical device and BioPharma entrepreneurs, major pharmaceutical companies, life science research leaders, policy makers and internationally prominent industry investors.
In addition to the professional exhibition and topic-trending conference, an array of Satellite Events will take place, and in order to maximize meetings and collaboration, an interactive online Networking System with dynamic search engine capabilities is offered.
We have started selling exhibition space and conference registration will begin in a few weeks.
The exhibition will showcase state-of-the-art exhibits from medical device, biotechnology and pharma companies. Trending topics have been identified and through this focused track approach, participants have the opportunity to gain a deeper understanding and more insight into the subjects.
This year we will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life sciences. The conference will be divided into 9 tracks:
- Digital Health, IoT, and Big Data – New Armamentarium in Medicine
- Next Generation Oncology Treatments
- Brain Health
- Personalized Diagnostics and Treatments
- Gene Editing and Therapies
- Nanomedicine and its Role in New Medical Therapeutics
- From Academia Research to Industry
- Cutting Edge Medical Device Technologies: Metabolic, Ophthalmology
- Novel Clinical Trial Designs and Technologies to Accelerate Drug Development